financetom
Business
financetom
/
Business
/
Pebblebrook Hotel Trust Refinances Near-Term Debt Maturities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pebblebrook Hotel Trust Refinances Near-Term Debt Maturities
Mar 11, 2026 3:58 AM

09:39 AM EST, 02/12/2026 (MT Newswires) -- Pebblebrook Hotel Trust ( PEB ) said Thursday it has refinanced its near-term debt maturities, extending its overall debt maturity schedule.

The transactions include a new $450 million senior unsecured term loan, early repayments of the Margaritaville Hollywood Beach Resort mortgage due in 2026, and the 2027 term loan.

The company also extended the remaining $48 million portion of the revolving credit facility, restoring total revolver capacity to $650 million through October 2029, including two optional six-month extensions.

As part of the financing, the company has eliminated 10-basis-point credit spread adjustment charge, saving on its annual interest expense.

Price: 12.96, Change: +0.12, Percent Change: +0.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AbbVie to buy Capstan Therapeutics for up to $2.1 billion
AbbVie to buy Capstan Therapeutics for up to $2.1 billion
Jun 30, 2025
(Reuters) -U.S. drugmaker AbbVie said on Monday it will acquire cell therapy developer Capstan Therapeutics in a cash deal worth up to $2.1 billion. Capstan develops CAR-T therapies, a type of treatment that uses a patient's own immune cells, specifically T cells, to fight diseases. Its main drug, CPTX2309, is currently in development for the treatment of autoimmune diseases. AbbVie...
AbbVie to Acquire Capstan Therapeutics for up to $2.1 Billion
AbbVie to Acquire Capstan Therapeutics for up to $2.1 Billion
Jun 30, 2025
08:43 AM EDT, 06/30/2025 (MT Newswires) -- AbbVie ( ABBV ) said Monday that it has agreed to acquire clinical-stage biotechnology company Capstan Therapeutics. AbbVie ( ABBV ) said it will pay up to $2.1 billion in cash at closing. ...
Great Lakes Dredge & Dock Awarded Four Dredging Contracts
Great Lakes Dredge & Dock Awarded Four Dredging Contracts
Jun 30, 2025
08:44 AM EDT, 06/30/2025 (MT Newswires) -- Great Lakes Dredge & Dock ( GLDD ) said Monday it has been awarded four dredging contracts, including the Woodside, Louisiana, LNG project for an undisclosed amount. The other awards are the $36.2 million Galveston Entrance Channel and Houston Ship Channel from Bolivar to Redfish maintenance project; the $17.6 million Mississippi River Hopper...
Copyright 2023-2026 - www.financetom.com All Rights Reserved